Man Group PLC Fortress Biotech, Inc. Transaction History

Man Group PLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$1.24 - $2.75 $112,424 - $249,328	-90,665 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$2.42 - $3.65 $32,447 - $48,939	-13,408 Reduced 12.88%	90,665 $227,000
Q3 2021 Nov 15, 2021	SELL	$2.82 - $3.7 $52,734 - $69,190	-18,700 Reduced 15.23%	104,073 $335,000
Q2 2021 Aug 16, 2021	SELL	$3.5 - $5.48 $123,963 - $194,090	-35,418 Reduced 22.39%	122,773 $438,000
Q1 2021 May 17, 2021	BUY	$3.16 - $4.89 $254,165 - $393,312	80,432 Added 103.44%	158,191 $558,000
Q4 2020 Feb 16, 2021	SELL	$2.2 - $4.45 $660 - $1,335	-300 Reduced 0.38%	77,759 $246,000
Q3 2020 Nov 16, 2020	BUY	$2.62 - $4.78 $204,514 - $373,122	78,059 New	78,059 $315,000

862K

Ticker FBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,735,000
Market Cap $173M
Description
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch sympt...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.